Company profilePharmaceutical#46 of 1,318 in Pakistan3 DRAP alerts

GLOBAL BRANDS DISTRIBUTORS

Pharmaceutical company · 249 brands · 220 molecules

Ranked #21 of 178 companies in Antiinflammatory And Antirheumatic Products

249 registered products 44 pharmaceutical brands 220 distinct molecules 3 DRAP alerts

Company overview

249
registered products
44
pharmaceutical brands
220
distinct molecules
11
therapeutic classes
3
DRAP alerts

GLOBAL BRANDS DISTRIBUTORS is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 249 product registrations across 220 distinct molecules. It is the 46th largest registrant in Pakistan by product count, and ranks 21st of 178 in Antiinflammatory And Antirheumatic Products. Its portfolio is concentrated in Antiinflammatory And Antirheumatic Products and Other Beta-Lactam, Cephalosporins & Penems. DRAP has issued 3 alerts involving its products.

Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.

Products by GLOBAL

7 products matched in our catalogue — each with its observed price and DRAP approved ceiling.

Drugs For Peptic Ulcer And Gastro-Oesophageal Reflux Disease (Gord) 2
Agents Against Amoebiasis And Other Protozoal Diseases 1

Price ceiling age

DRAP sets a maximum price per registration and revises it only on application. In a market with high inflation, an old ceiling erodes margin in real terms.

5
ceilings with an approval date
3
not revised in 2+ years
2024
oldest approval year
20243
20251
20261
Longest without revision

Top molecules by brand count

Nutritional Supplement / Multivitamin59 brands
Diclofenac7 brands
Artemether5 brands
Lumefantrine5 brands
Levofloxacin4 brands
Pyridoxine4 brands
Amlodipine3 brands
Thiamine3 brands

Therapeutic classes

Antiinflammatory And Antirheumatic Products · 8Other Beta-Lactam, Cephalosporins & Penems · 5Drugs For Peptic Ulcer And Gastro-Oesophageal Reflux Disease (Gord) · 4Drugs For Benign Prostatic Hypertrophy · 3Antimalarials · 3Opioids · 3Quinolone Antibacterials · 3Antidepressants · 2Macrolides, Lincosamides And Streptogramins · 2Drugs For Constipation · 2All Other Therapeutic Products, Antidotes · 2

Conditions treated

Bladder & Prostate Disorder · 2Neuropathic Pain/Epilepsy/Convulsion · 1Pain Killers · 1

Price band (DRAP official ceilings)

Registered products priced by source
DRAP-official46 products · Rs 6.24 – Rs 19,037
DVAGO5 products · Rs 91.8 – Rs 3,021
Servaid5 products · Rs 336.66 – Rs 1,430
Median across source: Rs 800

Regulatory record

3 alerts in the DRAP feed we track.

Directive on the security of online portals and engagement with authorized personnel/consu
2026-04-30
Rapid Alert: Drug Product Recall: Incidents of loss and damage of vision with the off-labe
2023-09-24
Recall Alert: Drug Product; Water for Injection (Batch #M21421) by M/s. Vision Pharmaceuti
2022-06-15

Competitive set

Companies whose registered portfolio overlaps most with this one.

Portfolio whitespace

Molecules the closest competitors have registered and this company has not — the starting point for a launch shortlist.

Wilshire Laboratories (Private) Limited holds 129 molecules not in this portfolio
AcyclovirAcyclovir SodiumAlfacalcidolAmlodipineAmoxicillinAmoxycillin
ZAFA PHARMACEUTICAL LABORATORIES (PVT) LTD. holds 153 molecules not in this portfolio
AlbuterolAmikacinAminophyllineAmlodipineAmlodipine BaseAmmonium Chloride
Genix Pharma Private Limited holds 154 molecules not in this portfolio
000 I.UAceclofenacAcyclovirAlbendazoleAlfacalcidolAmikacin

Get the full profile for GLOBAL

This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.

Request this brief See what’s included

Company data as of 2026-07-30. Brand and molecule counts from the DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.